NCT00816673View on ClinicalTrials.gov

Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

May 31, 1997

Study Completion Date

September 30, 1997

Conditions
Primary Insomnia
Interventions
DRUG

placebo Circadin

Placebo tabs of Prolonged release melatonin

DRUG

Circadin

prolonged release melatonin 2 mg taken daily 2 hours before bed-time for 3 weeks

Trial Locations (1)

F-68250

FORENAP, Centre Hospitalier de Rouffach

Sponsors
All Listed Sponsors
lead

Neurim Pharmaceuticals Ltd.

INDUSTRY

NCT00816673 - Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs | Biotech Hunter | Biotech Hunter